Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance - Quiz - MDSpire

Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance

  • By

  • Molly Javier Uyeda

  • Audrey Re

  • Chunyi Tang

  • Melissa McLaughlin

  • Daryl Humes

  • Steven Sexton

  • Robert Freeborn

  • Isaura Villalba

  • Kevin Nugent

  • James Adams

  • Jie Wei

  • Matt Breton

  • Xavier Paliard

  • Maximilian Richter

  • Maria Grazia Roncarolo

  • Ryan Bjordahl

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance

  • by Molly Javier Uyeda, Audrey Re, Chunyi Tang, Melissa McLaughlin, Daryl Humes, Steven Sexton, Robert Freeborn, Isaura Villalba, Kevin Nugent, James Adams, Jie Wei, Matt Breton, Xavier Paliard, Maximilian Richter, Maria Grazia Roncarolo, Ryan Bjordahl

  • July 9, 2026

Related Content

Systemic immune-inflammation Index is an independent risk factor for Major adverse cardiovascular events in patients with coronary artery ectasia

Assessing the risk of adverse drug events from combining aromatase inhibitors with CDK4/6 inhibitors using the FAERS and JADER databases

Correction: Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies